Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Big Ideas: Technological Breakthroughs Investors Shouldn’t Miss in 2020
02:00pm, Wednesday, 22'nd Jan 2020
ARK Invest has identified five innovation platforms that are evolving today and causing an increased amount of new technological breakthroughs. Companies that are leading and benefiting from these tec
Big Things Are Happening With This Genomics ETF
01:00pm, Wednesday, 22'nd Jan 2020
Investors looking for the intersection of healthcare and disruption need to look to genomics and DNA sequencing, two of the core focuses of the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). A
Drugmakers getting creative over ways to pay for pricey meds
05:16pm, Monday, 13'th Jan 2020
Faced with pushback from multiple fronts over high drug prices, biopharmaceutical firms are experimenting with new ways to get paid for their priciest offerings, mostly biologics, in a report from the
California mulling private-label generics to address high drug costs
03:05pm, Thursday, 09'th Jan 2020
The new budget proposed by California Governor Gavin Newsom includes a plan to allow the state to contract with generic drug makers to provide medicines to all Californians. He believes that the gover
Illumina Stock Could Illuminate This Healthcare ETF
04:14pm, Monday, 06'th Jan 2020
Biotech firm Illumina, Inc. (ILMN) scrapped a merger with Pacific Biosciences, but there's still a lot to like about Illumina and for investors that can't handle the stock's over $300 price tag, the
Get Giddy For Genomics With This ETF
04:18pm, Monday, 23'rd Dec 2019
With healthcare and, more specifically, biotechnology stocks and ETFs on the mend, investors may want to consider getting tactical and focusing on one of the arena’s most potent growth avenues: geno
ARK Investment Management LLC (ARK or ARK Invest), a New York-based investment adviser focused solely on disruptive innovation in the public equity markets, announced today plans to change the primary
Actively Managed ETFs Provide Forward-Looking Strategies
09:48pm, Thursday, 19'th Dec 2019
Some money managers may loathe the idea of revealing their methodology in a fully transparent actively managed ETF, but others have fully embraced the investment vehicle to provide greater value to in
Genomic ETF Up 40%-Plus This Year, Approaches New Buy Point
10:33pm, Thursday, 12'th Dec 2019
RK Genomic Revolution ETF is up more than 40% this year, making it one of the top ETFs of 2019. But to participate in that gain, investors had to time their buys carefully.
Genomic ETF Up 40%-Plus This Year, Approaches New Buy Point
12:00am, Thursday, 12'th Dec 2019Why Biotech ETFs are Surging to New Highs
09:16pm, Tuesday, 10'th Dec 2019
increasing M&A; deals and cutting edge therapies are driving biotech ETFs higher
A Guide to Biotech ETF Investing
07:40pm, Monday, 02'nd Dec 2019
Increasing M&A; deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.
